SCHEMBL5064933

SCHEMBL5064933

CN(C)C(=O)c1cc(OCc2ccccc2)c(F)cc1N

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.47
NPC1 O15118 1/20 0.45
CYP19A1 P11511 1/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 2/20 0.44
MRGPRX4 Q96LA9 2/20 0.42
LRRK2 Q5S007 1/20 0.42
PTGER1 P34995 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
S1PR5 Q9H228 1/20 0.41
APP P05067 1/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
KMT2A Q03164 1/20 0.41
FOLH1 Q04609 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5065136 0.86 HTT (0.51) BRD4NPC1CYP19A1LMNAHTT
SCHEMBL582711 0.85 FOLH1 (0.51) BRD4NPC1LMNAHTTMRGPRX4
SCHEMBL11922623 0.84 NPC1 (0.49) BRD4NPC1LMNAHTTMRGPRX4
SCHEMBL2684149 0.81 ALDH1A1 (0.49) BRD4NPC1LMNAHTTMRGPRX4
SCHEMBL5065157 0.81 CTSV (0.50) BRD4NPC1CYP19A1CTSVCTSL
SCHEMBL14050174 0.78 THRA (0.42) LMNAHTTALDH1A1KMT2A
SCHEMBL20401088 0.78 CYP19A1 (0.56) BRD4CYP19A1LRRK2ALDH1A1SMN1; SMN2
SCHEMBL5065166 0.78 MAOB (0.53) SMN1; SMN2KMT2A
SCHEMBL7430696 0.78 LTA4H (0.49) NPC1CYP19A1MRGPRX4PTGER1MAPK1
SCHEMBL12726937 0.77 TRPM8 (0.58) BRD4NPC1LMNAHTTPTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432392-B2 Ester derivatives and medical use thereof JAPAN TOBACCO INC. (JP) 2008-10-07 US disclosed
US-7432392-B2 Ester derivatives and medical use thereof JAPAN TOBACCO INC. (JP) 2008-10-07 US disclosed
US-20060205726-A1 Ester derivatives and medical use thereof JAPAN TOBACCO INC. (JP) 2006-09-14 US disclosed
EP-1669345-A1 ESTER DERIVATIVE AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205726-A1 Ester derivatives and medical use thereof MTTP, LIPC, CETP BRD4 3044/4885NPC1 28/4885CYP19A1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.